Fibrinolytic and Thrombotic disorders (CH15 & 22) Flashcards

1
Q

What is important to understand about the

fibrinolytic system ?

A
  • it is in balance with the coagulation system
  • if fibrinolytic activity is substantially increased bleeding may occur even if the coagulation system and platelets are functioning ok.
  • activity may be increased due to increased plasminogen activators or reduced levels of fibrinolytic inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In what situation can fibrinolytic bleeding

occur at the same time as dysregulated hemostasis ?

A
  • DIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When would you consider working up

a patient for atypical or a disorder of fibrinolysis ?

A
  • history of bleeding
  • negative results on the more common coagulation assays
  • bleeding due to abnormal fibrinolysis is rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the clinical presenation in disorders

of fibrinolysis ?

A
  • delayed bleeding after surgery, trauma or childbirth
  • wound hematomas (can be severe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are acquired causes of

fibrinolytic disorders ?

A
  • cirrhosis
  • liver transplantation
  • trauma
  • cardiopulmonary bypass
  • DIC
  • treatment of thrombosis with excess plasminogen activators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IMP limitation of TEG

and ROTEM in evaluting fibrinolysis

A
  • lack of evidence of lysis on these tests does not rule out moderately increased fibrinolysis that may be clinically significant
    • ex:
    • plasminogen active inhibitor I deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the inheritance pattern

and general information about plasminogen activator inhibtor 1

deficiency?

A
  • rare congenital disorder
  • homozygous, autosomal recessive
  • increased fibrinolysis leading to excessive bleeding
  • PAI-1 antigen levels are undetectable in plasma samples
    • means a complete deficiency

IMP: however patients with normal antigen and reduced activity, heterozygosity etc have been described

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the clinical presentation of

PAI-1 deficiency?

A
  • easy bruising
  • menorrhagia
  • moderate to severe delayed bleeding after surgery or minor trauma
  • often have excessive wound hematomas
  • bleeding episodes include intracranial bleeding or joint bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is unclear about PAI-1 deficiency in

either the antigen or activity ?

A
  • if low normal antigen levels and activity do truly lead to increased bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should the lab evaluation of

PAI-1 include ?

A
  • PAI-1 activity
  • PAI-1 antigen
  • total tPA antigen or tPA-PAI-1 complex

Note: samples should be drawn in the morning when PAI-1 is highest

GREAT chart p. 202

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In patients with PAI-1 deficiency

why is the amount of tPA antigen reduced ?

A
  • the tPA-PAI-1 complex will be decreased to absent
  • majority of the tPA will be in the free, unbound form
    • which gets cleared quickly by the liver

IMP: must demonstrate a low tPA antigen level or tPA-PAI-1 complex when diagnosing PAI-1 deficiency in addition to the low PAI-1 activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should a spurious result of

PAI-1 deficiency be suspected?

A
  • low PAI-1 activity
  • normal or high tPA antigen level

IMP: this denotes a sampling problem (may have prolonged tourniquet time etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is similar between normal patients

and those with PAI-1 deficiency ?

A
  • tPA activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Since circulating, active tPA is similar between normal patients and

those with PAI-1 deficiency, why do PAI-1

deficiency patients bleed?

A
  • PAI-1 binds to the clot surface and is important to inhibiting tPA activity at that junction
    • so in PAI-1 deficiency the clot is more subject to thrombolysis and hence these patients bleed more
    • despite equivalent levels of blood tPA activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What types of deficiencies

of alpha-2 antiplasmin have been described ?

A
  • homozygous (very rare)
    • autosomal recessive
    • moderate to severe bleeding
  • heterozygous (rare)
    • controversial amount of bleeding
    • similar to PAI-1 deficiency (moderate)
      • post-operative bleeding, wound hematomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the clinical presentation of

homozygous deficiency of alpha-2 antiplasmin ?

A
  • moderate to severe bleeding that begins in childhoos
    • umbilical bleeding
    • easy bruising
    • hemarthrosis
    • gingival bleeding
    • prolonged hemorrhage after minor trauma or dental procedures
    • rebleeding of wound hematomas
    • intramedullary bleeding in the diaphesis of long bones
17
Q

Quebec platelet disorder is what?

A
  • autosomal dominant disorder
  • moderate to severe bleeding after surgery or trauma
  • multiple defects
    • low platelet counts
    • abnormal platelet aggregation studies
    • decreased platelet alpha granules
18
Q

What is the principle problem in

Quebec platelet disorder ?

A
  • tandem duplication mutation of the urokinase plasminogen activator gene
  • leads to an increase in uroplasminogen activator (uPA)
    • leads to degradation of granule proteins in platelets
    • release of uPA in the platelet alpha granules
    • accelerated clot lysis
19
Q

What is the role of Factor XIII and

how does it’s deficiency lead to bleeding ?

A
  • Factor XIII cross links fibrin strands and alpha 2 antiplasmin to fibrin
    • this causes resistance to fibrinolysis
  • deficiency
    • rare autosomal recessive disorder
    • acquired anti-XIII antibodies
20
Q

What is the clinical presentation

of Factor XIII deficiency ?

A
  • delayed bleeding, impaired woudn healing
  • spontaneous abortions
  • bleeding is often due to premature clot lysis
21
Q

What are the acquired causes of

fibrinolytic bleeding ?

A
  • in general, acquired causes are more common than inherited
  • causes of increased tPA levels (increased secretion)
    • elecric shock
    • complecated labor
    • cardiopulmonary bypass
    • trauam
  • causes of decreased tPA clearance
    • cirrhosis
    • liver transplantation

read pg. 204-210 for further details

22
Q

Is PAI-1 an acute phase reactant ?

A
  • yes
  • it increases in DIC and paradoxically decreases the fibrinolytic system leading to thrombosis
23
Q

What factors are degraded by plasmin ?

A
  • Fibrin
  • fibrinogen
  • Factor V
  • Factor VII
  • Factor XIII